Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Inventory Average: 2019-2024

Historic Inventory Average for Akebia Therapeutics (AKBA) over the last 6 years, with Dec 2024 value amounting to $16.0 million.

  • Akebia Therapeutics' Inventory Average fell 20.32% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 20.32%. This contributed to the annual value of $16.0 million for FY2024, which is 14.29% down from last year.
  • As of FY2024, Akebia Therapeutics' Inventory Average stood at $16.0 million, which was down 14.29% from $18.6 million recorded in FY2023.
  • Akebia Therapeutics' 5-year Inventory Average high stood at $88.7 million for FY2020, and its period low was $16.0 million during FY2024.
  • Over the past 3 years, Akebia Therapeutics' median Inventory Average value was $18.6 million (recorded in 2023), while the average stood at $21.2 million.
  • Data for Akebia Therapeutics' Inventory Average shows a maximum YoY slumped of 44.95% (in 2021) over the last 5 years.
  • Over the past 5 years, Akebia Therapeutics' Inventory Average (Yearly) stood at $88.7 million in 2020, then slumped by 44.95% to $48.8 million in 2021, then crashed by 40.40% to $29.1 million in 2022, then slumped by 35.98% to $18.6 million in 2023, then decreased by 14.29% to $16.0 million in 2024.